{"id":925600,"date":"2026-01-08T17:17:16","date_gmt":"2026-01-08T22:17:16","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/merit-medical-appoints-f-ann-millner-as-chair-of-the-board-and-announces-projected-preliminary-unaudited-revenue-results-for-the-fourth-quarter-of-2025\/"},"modified":"2026-01-08T17:17:16","modified_gmt":"2026-01-08T22:17:16","slug":"merit-medical-appoints-f-ann-millner-as-chair-of-the-board-and-announces-projected-preliminary-unaudited-revenue-results-for-the-fourth-quarter-of-2025","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/merit-medical-appoints-f-ann-millner-as-chair-of-the-board-and-announces-projected-preliminary-unaudited-revenue-results-for-the-fourth-quarter-of-2025\/","title":{"rendered":"Merit Medical Appoints F. Ann Millner as Chair of the Board and Announces Projected Preliminary Unaudited Revenue Results for the Fourth Quarter of 2025"},"content":{"rendered":"<div class=\"mw_release\">\n<p>SOUTH JORDAN, Utah, Jan.  08, 2026  (GLOBE NEWSWIRE) &#8212; Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader in healthcare technology, today announced that its Board of Directors unanimously appointed F. Ann Millner, Ed.D., formerly Merit\u2019s Lead Independent Director, as Chair of the Board effective January 5, 2026.<\/p>\n<p>Dr. Millner has served as a director of Merit since 2015 and as the Lead Independent Director since July 2021. She previously served as the Chair of Merit\u2019s Governance and Sustainability Committee. Dr. Millner currently serves as a member of the Utah State Senate, to which she was elected in 2015. She served as the President of Weber State University from 2002 through 2012 and as the Regents Professor and Professor of Health Administrative Services at Weber State University from 2013 through 2025.<\/p>\n<p>Fred P. Lampropoulos informed the Board of Directors of his resignation as a director and Chair of the Board on January 4, 2026. This followed the conclusion of Mr. Lampropoulos\u2019 employment as Executive Chair of the Board on January 3, 2026 pursuant to the Company\u2019s CEO Transition Agreement, and his resignation as Merit\u2019s President and Chief Executive Officer on October 3, 2025. Mr. Lampropoulos and Merit have entered into a consulting agreement through March 31, 2026.<\/p>\n<p>\u201cAs I step down after 38 years since founding Merit, I am proud of how far we\u2019ve come and believe the company is stronger than ever,\u201d said Mr. Lampropoulos. \u201cThe management team and the Board are well positioned to guide Merit\u2019s talented employees forward. Their commitment to excellence and innovation will further Merit\u2019s mission of delivering products that improve lives around the world.\u201d<\/p>\n<p>Mr. Lampropoulos\u2019 resignation is not the result of a dispute or disagreement with Merit\u2019s management or Board of Directors, nor any matter related to Merit\u2019s financial reporting, internal controls, operations, policies, or business practices.<\/p>\n<p>\u201cFred\u2019s vision and leadership have been instrumental in building Merit into the global healthcare company it is today,\u201d said Dr. Millner. \u201cOn behalf of the Board and the entire organization, I want to express our gratitude for his decades of service and commitment to improving patient care. Merit remains focused on strong execution towards achievement of our Continued Growth Initiatives and related financial targets for the three-year period ending December 31, 2026 and delivering value to our customers, employees, and shareholders.\u201d<\/p>\n<p>\n        <strong>PRELIMINARY REVENUE RESULTS FOR FOURTH QUARTER 2025 <\/strong>\n      <\/p>\n<ul>\n<li>Fourth quarter 2025 reported preliminary unaudited revenue in the range of approximately $389 million to $395 million, up approximately 10% to 11% year-over-year.<\/li>\n<li>Fourth quarter 2025 preliminary unaudited constant currency revenue<sup>*<\/sup> increased in the range of approximately 8% to 10% year-over-year.\n<\/li>\n<\/ul>\n<p>\n        <em>*\u00a0Constant currency revenue is a non-GAAP financial measure. A reconciliation of this financial measure to its most directly comparable GAAP financial measure is included under the heading \u201cNon-GAAP Financial Measure\u201d below.<\/em>\n      <\/p>\n<p align=\"justify\">\n        <strong><br \/>\n          <u>CONFERENCE CALL<\/u><br \/>\n        <\/strong>\n      <\/p>\n<p align=\"justify\">Merit plans to announce its financial results for the quarter and year ended December 31, 2025, and issue fiscal year 2026 guidance after the close of the stock market on Tuesday, February 24, 2026. Merit plans to hold its investor conference call on the same day (Tuesday, February 24, 2026) at 4:30 p.m. Eastern (3:30 p.m. Central, 2:30 p.m. Mountain, and 1:30 p.m. Pacific).<\/p>\n<p align=\"justify\">\n        <strong>To access the conference call, please pre-register using the following <\/strong><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ZhPdIDl2f6GAWL8uyg_2bMsx5esuykASD5WTL0kDEjLZRYftnd4M34m2DmEXFWEV9gzP4_ADAIzz-lB7_BJZHbFv1g3NAWVi-MemS0THhmMISzkxFiSbZr4ZCBOuXOEthzKVohT6xj10xhjntSBfkYH-gM01ghTjanKV4CfI8GVlbRj2VeW9Z3OGsSY5RUYd2ObMUvI9sLWHB_KWIV2x7zoQp6Zh5nAXOY6wGF2kxentol1-8e2SEoEPasIKIvDVqUgKVj-2GhsMgL85UAojAteXrtpdlv9f3igTb0rBUu_AdRIGscT5NVzxl1tdq4LH_G8YC6_qiiU_DPV9YeshI-Ng_-v_3clwAqoecQRYNyyS2nWIEh0GaXN_4Ah46jmhV8X9fiqM492XR6yjDpOHZzh4ysOEQQVTP6O_xgSfwAcHnK2WhUF-aShvLq6WkOcG\" rel=\"nofollow\" target=\"_blank\"><br \/>\n          <strong>link<\/strong><br \/>\n        <\/a><br \/>\n        <strong>. <\/strong><br \/>\n        <strong>Registrants will receive confirmation with dial-in details. <\/strong>\n      <\/p>\n<p align=\"justify\">A live webcast and slide deck can be accessed using this <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ZhPdIDl2f6GAWL8uyg_2bCH8OVzroV47TizGHL_RKkMB5SGEXFanRwRnVdluThs7WsqpVp979_NdlXBidWimKziRv9C0v_sXm0X5MR3ulbZYYnoS7xkWaclgVlvQNfrHTGXczV1Y2H5CSl3JT6F_p7-bV7mSIGjtOhR8-CDg8j3jDoWde2V-Y-lLpTzIuI11aGiR1nF33O0kxAAmqZpEsCHAc0Zfoki1Jlk8_v9GFz7d_qWUApo7mH7USA2-2dk4ZhTEqgoyZq7sQVZOEYX8j9C5ZpgAvA63PvV9jtdSzVWyROuneKrjJlC1PKYG9LYWWJ15BB2HXrxVjy2TXC3cUuoTxmN9odOen3Rsnl6uA6RhCqVc7QwG3WWsZ81UxJ1V9SYIrdR75opyz-uG6w0aUg==\" rel=\"nofollow\" target=\"_blank\"><strong>link<\/strong><\/a><strong>. <\/strong>A link to both register for the conference call and view the webcast will be made available at www.merit.com.<\/p>\n<p>\n        <u>Non-GAAP Financial Measure<\/u>\n      <\/p>\n<p align=\"justify\">Although Merit\u2019s financial statements are prepared in accordance with accounting principles generally accepted in the United States of America (\u201cGAAP\u201d), Merit\u2019s management believes that the non-GAAP financial measure of constant currency revenue referenced in this release may provide investors with useful information regarding the underlying business trends and performance of Merit\u2019s ongoing operations and can be useful for period-over-period comparisons of such operations.<\/p>\n<p align=\"justify\">Merit\u2019s management team uses this non-GAAP financial measure to evaluate Merit\u2019s profitability and efficiency, to compare operating and financial results to prior periods, to evaluate changes in the results of its operating segments, and to measure and allocate financial resources internally. However, Merit\u2019s management does not consider this non-GAAP measure in isolation or as an alternative to measures determined in accordance with GAAP.<\/p>\n<p align=\"justify\">Readers should consider the non-GAAP measure used in this release in addition to, not as a substitute for, financial reporting measures prepared in accordance with GAAP. This non-GAAP financial measure generally excludes some, but not all, items that may affect Merit\u2019s net income. In addition, it is subject to inherent limitations as it reflects the exercise of judgment by management about which items are excluded. The non-GAAP financial measure used in this release may not be comparable with similarly titled measures of other companies. Merit urges readers to review the reconciliation of the non-GAAP financial measure to its most directly comparable GAAP financial measure included herein, and not to rely on any single financial measure to evaluate Merit\u2019s business or results of operations.<\/p>\n<p>\n        <strong>Constant Currency Revenue<\/strong>\n      <\/p>\n<p align=\"justify\">Merit\u2019s constant currency revenue is prepared by converting the current-period reported revenue of subsidiaries whose functional currency is a currency other than the U.S. dollar at the applicable foreign exchange rates in effect during the comparable prior-year period and adjusting for the effects of hedging transactions on reported revenue, which are recorded in the U.S. dollar. The preliminary approximate constant currency revenue adjustment of $(4.4) million to preliminary approximate reported revenue for the three-month period ended December 31, 2025 was calculated using the applicable average foreign exchange rates for the three-month period ended December 31, 2024.<\/p>\n<p>\n        <strong>Non-GAAP Financial Measure Reconciliation<\/strong>\n      <\/p>\n<p>The following table sets forth supplemental financial data and corresponding reconciliation of non-GAAP preliminary constant currency revenues to Merit\u2019s corresponding financial measure prepared in accordance with GAAP for the three-month period ended December 31, 2025.<\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"vertical-align: bottom\">\u00a0<\/td>\n<td style=\"vertical-align: bottom\">\u00a0<\/td>\n<td style=\"text-align: center;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"vertical-align: bottom\">\u00a0<\/td>\n<td style=\"vertical-align: bottom\">\u00a0<\/td>\n<td colspan=\"7\" style=\"text-align: center;vertical-align: middle;vertical-align: bottom\">Three Months Ended<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: bottom\">\u00a0<\/td>\n<td style=\"vertical-align: bottom\">\u00a0<\/td>\n<td style=\"text-align: center;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"vertical-align: bottom\">\u00a0<\/td>\n<td style=\"vertical-align: bottom\">\u00a0<\/td>\n<td colspan=\"7\" style=\"text-align: center;vertical-align: middle;vertical-align: bottom\">December\u00a031,\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: bottom\">\u00a0<\/td>\n<td style=\"vertical-align: bottom\">\u00a0\u00a0\u00a0\u00a0<\/td>\n<td style=\"border-bottom: solid black 1pt;text-align: center;vertical-align: middle;vertical-align: bottom\">%\u00a0Change<\/td>\n<td style=\"vertical-align: bottom\">\u00a0\u00a0\u00a0<\/td>\n<td style=\"vertical-align: bottom\">\u00a0<\/td>\n<td colspan=\"3\" style=\"border-bottom: solid black 1pt;padding-right: 0;text-align: center;vertical-align: middle;vertical-align: bottom\">2025<\/td>\n<td style=\"text-align: center;vertical-align: middle;vertical-align: bottom\">\u00a0\u00a0\u00a0\u00a0<\/td>\n<td colspan=\"3\" style=\"border-bottom: solid black 1pt;text-align: center;vertical-align: middle;vertical-align: bottom\">2024<\/td>\n<\/tr>\n<tr>\n<td style=\"max-width:59%;width:59%;min-width:59%;vertical-align: top;vertical-align: bottom\">Preliminary Unaudited Revenue Range (a)<\/td>\n<td style=\"max-width:1%;width:1%;min-width:1%;vertical-align: top;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"max-width:11%;width:11%;min-width:11%;text-align: center;vertical-align: middle;vertical-align: top;vertical-align: bottom\">10 \u2013 11<\/td>\n<td style=\"max-width:1%;width:1%;min-width:1%;vertical-align: top;vertical-align: bottom\">%\u00a0\u00a0<\/td>\n<td style=\"max-width:1%;width:1%;min-width:1%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"max-width:1%;width:1%;min-width:1%;vertical-align: top;vertical-align: bottom\">$<\/td>\n<td style=\"max-width:11%;width:11%;min-width:11%;text-align: right;vertical-align: middle;vertical-align: top;vertical-align: bottom\">389,000 &#8211; 395,000<\/td>\n<td style=\"max-width:1%;width:1%;min-width:1%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"max-width:1%;width:1%;min-width:1%;vertical-align: top;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"max-width:1%;width:1%;min-width:1%;vertical-align: top;vertical-align: bottom\">$<\/td>\n<td style=\"max-width:11%;width:11%;min-width:11%;text-align: right;vertical-align: middle;vertical-align: top;vertical-align: bottom\">355,158<\/td>\n<td style=\"max-width:1%;width:1%;min-width:1%;vertical-align: bottom\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"vertical-align: top;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"text-align: center;vertical-align: middle;vertical-align: top;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"vertical-align: top;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"vertical-align: bottom\">\u00a0<\/td>\n<td style=\"vertical-align: top;vertical-align: bottom\">\u00a0<\/td>\n<td colspan=\"2\" style=\"vertical-align: top;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"vertical-align: top;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"vertical-align: top;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"vertical-align: top;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"vertical-align: bottom\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"max-width:47%;min-width:47%;vertical-align: top;vertical-align: bottom\">\n            <em>Add: Impact of foreign exchange<\/em>\n          <\/td>\n<td style=\"max-width:3%;min-width:3%;vertical-align: top;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"max-width:11%;min-width:11%;text-align: center;vertical-align: middle;vertical-align: top;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"max-width:4%;min-width:4%;vertical-align: top;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"max-width:4%;min-width:4%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"max-width:2%;min-width:2%;vertical-align: top;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"max-width:17%;min-width:17%;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top;vertical-align: bottom\">(4,400<\/td>\n<td style=\"max-width:1%;min-width:1%;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: top;vertical-align: bottom\">)<\/td>\n<td style=\"max-width:3%;min-width:3%;vertical-align: top;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"max-width:2%;min-width:2%;vertical-align: top;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"max-width:10%;min-width:10%;text-align: right;vertical-align: middle;vertical-align: top;vertical-align: bottom\">\u2014<\/td>\n<td style=\"max-width:10%;min-width:10%;vertical-align: bottom\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"vertical-align: top;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"text-align: center;vertical-align: middle;vertical-align: top;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"vertical-align: top;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"vertical-align: bottom\">\u00a0<\/td>\n<td style=\"border-bottom: solid black 1pt;vertical-align: top;vertical-align: bottom\">\u00a0<\/td>\n<td colspan=\"2\" style=\"border-bottom: solid black 1pt;vertical-align: top;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"vertical-align: top;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"border-bottom: solid black 1pt;vertical-align: top;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"border-bottom: solid black 1pt;vertical-align: top;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"border-bottom: solid black 1pt;vertical-align: bottom\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top;vertical-align: bottom\">Preliminary Constant Currency Revenue (b)<\/td>\n<td style=\"vertical-align: top;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"text-align: center;vertical-align: middle;vertical-align: top;vertical-align: bottom\">8 \u2013 10<\/td>\n<td style=\"vertical-align: top;vertical-align: bottom\">%\u00a0<\/td>\n<td style=\"vertical-align: bottom\">\u00a0<\/td>\n<td style=\"border-bottom: double black 3pt;vertical-align: top;vertical-align: bottom\">$<\/td>\n<td style=\"border-bottom: double black 3pt;text-align: right;vertical-align: middle;vertical-align: top;vertical-align: bottom\">384,600 &#8211; 390,600<\/td>\n<td style=\"border-bottom: double black 3pt;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"vertical-align: top;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"border-bottom: double black 3pt;vertical-align: top;vertical-align: bottom\">$<\/td>\n<td style=\"border-bottom: double black 3pt;text-align: right;vertical-align: middle;vertical-align: top;vertical-align: bottom\">355,158<\/td>\n<td style=\"border-bottom: double black 3pt;vertical-align: bottom\">\u00a0<\/td>\n<\/tr>\n<\/table>\n<p align=\"justify\">_______________<\/p>\n<p align=\"justify\">(a)\u00a0\u00a0\u00a0US dollar, thousands. Amounts in this table are rounded while percentages are calculated from the underlying amounts.<\/p>\n<p align=\"justify\">(b)\u00a0\u00a0\u00a0A non-GAAP financial measure. For a definition of this non-GAAP financial measure, see the section of this release entitled \u201cNon-GAAP Financial Measure.\u201d<\/p>\n<p>\n        <strong>ABOUT MERIT MEDICAL<\/strong><br \/>\n        <br \/>Founded in 1987, Merit Medical Systems, Inc. is engaged in the development, manufacture, and distribution of proprietary medical devices used in interventional, diagnostic, and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care, and endoscopy. Merit serves customers worldwide with a domestic and international sales force and clinical support team totaling more than 800 individuals. Merit employs approximately 7,500 people worldwide.<\/p>\n<p>\n        <strong>CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS<\/strong>\n      <\/p>\n<p>This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements include, among others:<\/p>\n<ul>\n<li>statements preceded or followed by, or that include the words, \u201cmay,\u201d \u201cwill,\u201d \u201cshould,\u201d \u201cexpects,\u201d \u201cplans,\u201d \u201canticipates,\u201d \u201cintends,\u201d \u201cseeks,\u201d \u201cbelieves,\u201d \u201cestimates,\u201d \u201cprojects,\u201d \u201cforecasts,\u201d \u201cpotential,\u201d \u201ctarget,\u201d \u201ccontinue,\u201d \u201cupcoming,\u201d \u201coptimistic\u201d or other forms of these words or similar words or expressions, or the negative thereof or other comparable terminology;\n<\/li>\n<li>statements that address Merit\u2019s future operating performance or events or developments that Merit\u2019s management expects or anticipates will occur, including, without limitation, any statements regarding Merit\u2019s projected revenues, earnings or other financial measures, Merit\u2019s plans and objectives for future operations, Merit\u2019s proposed new products or services, the integration, development or commercialization of the business or any assets acquired from other parties, future economic conditions or performance, the implementation of, and results which may be achieved through, Merit\u2019s Continued Growth Initiatives Program or other business optimization initiatives, and any statements of assumptions underlying any of the foregoing; and\n<\/li>\n<li>statements regarding Merit\u2019s past performance, efforts, or results about which inferences or assumptions may be made, including statements proceeded or followed by the words &#8220;preliminary,&#8221; &#8220;initial,&#8221; &#8220;potential,&#8221; &#8220;possible,&#8221; &#8220;diligence,&#8221; &#8220;industry-leading,&#8221; &#8220;compliant,&#8221; &#8220;indications,&#8221; or &#8220;early feedback&#8221; or other forms of these words or similar words or expressions, or the negative thereof or other comparable terminology.\n<\/li>\n<\/ul>\n<p>The forward-looking statements contained in this release are based on Merit management\u2019s current expectations and assumptions regarding future events or outcomes. If underlying expectations or assumptions prove inaccurate, or risks or uncertainties materialize, actual results will likely differ, and may differ materially, from Merit\u2019s expectations reflected in any forward-looking statements. Financial estimates are subject to change and are not intended to be relied upon as predictions of future operating results. Investors are cautioned not to unduly rely on any such forward-looking statements.<\/p>\n<p>The following are some of the important risks and uncertainties that could cause Merit\u2019s actual results to differ from management\u2019s expectations in any forward-looking statements: risks and uncertainties associated with Merit\u2019s executive succession planning activities and leadership transition; risks and uncertainties regarding trade policies or related actions implemented by the U.S. or other countries, including existing, proposed or prospective tariffs, duties or other measures; risks and uncertainties associated with Merit\u2019s integration of the C2 CryoBalloon device and related assets acquired from Pentax of America, Inc. in November 2025 and Merit\u2019s ability to achieve financial results, product development and other anticipated benefits of such acquisition; risks and uncertainties associated with Merit\u2019s integration of the business and operations of Biolife Delaware, L.L.C. acquired in May 2025 and its ability to achieve financial results, product development and other anticipated benefits of such acquisition; effects of Merit\u2019s 3.00% Senior Convertible Notes on Merit\u2019s net income and earnings per share performance; disruptions in Merit\u2019s supply chain, manufacturing or sterilization processes; U.S. and global political, economic, competitive, reimbursement and regulatory conditions; modification or limitation of, or policies and procedures associated with, governmental or private insurance reimbursement policies; reduced availability of, and price increases associated with, components and other raw materials; increases in transportation expenses; risks relating to Merit\u2019s potential inability to successfully manage growth through acquisitions generally, including the inability to effectively integrate acquired operations or products or commercialize technology developed internally or acquired through completed, proposed or future transactions; fluctuations in interest or foreign currency exchange rates and inflation; cybersecurity events; government scrutiny and regulation of the medical device industry; difficulties relating to development, testing and regulatory approval, clearance and maintenance of Merit\u2019s products; the safety, efficacy and patient and physician adoption of Merit\u2019s products; the ability to fully enroll and the outcomes of ongoing and future clinical trials and market studies relating to Merit\u2019s products; litigation and other judicial proceedings affecting Merit; failure to comply with U.S. and foreign laws and regulations; restrictions on Merit\u2019s liquidity or business operations resulting from its debt agreements; infringement of Merit\u2019s technology or the assertion that Merit\u2019s technology infringes the rights of other parties; product recalls and product liability claims; potential for significant adverse changes in governing regulations; changes in tax laws and regulations in the United States or other jurisdictions or exposure to additional tax liabilities which may adversely affect Merit\u2019s effective tax rate; termination of relationships with Merit\u2019s suppliers, or failure of such suppliers to perform; development of new products and technology that could render Merit\u2019s existing or future products obsolete; market acceptance of new products; failure to comply with applicable environmental laws; changes in key personnel; labor shortages and increases in labor costs; price and product competition; extreme weather events; and geopolitical events. For a further discussion of the risks and uncertainties which may affect Merit\u2019s business, operations and financial condition, see Part I, Item 1A. \u201cRisk Factors\u201d in Merit\u2019s Annual Report on Form 10-K for the year ended December 31, 2024 filed with the SEC, which Merit updated in Part II, Item 1A. \u201cRisk Factors\u201d in Merit\u2019s Quarterly Reports on Form 10-Q for each of the quarters ended March 31, 2025, June 30, 2025 and September 30, 2025, which Merit filed with the SEC.<\/p>\n<p>All subsequent forward-looking statements attributable to Merit or persons acting on its behalf are expressly qualified in their entirety by these cautionary statements. Actual results will likely differ, and may differ materially, from anticipated results. Financial estimates are subject to change and are not intended to be relied upon as predictions of future operating results. Those estimates and all other forward-looking statements included in this release are made only as of the date of this release, and except as otherwise required by applicable law, Merit assumes no obligation to update or disclose revisions to estimates and all other forward-looking statements.<\/p>\n<p>Merit does not, as a matter of course, publicly disclose preliminary unaudited revenue, whether on an annual or quarterly basis, due to the unpredictability of the underlying assumptions and estimates. Merit\u2019s announcement of preliminary unaudited revenue information in this release should not be regarded as an indication that Merit considered, or now considers, preliminary unaudited revenue information to be material or to be a reliable prediction of actual future results, and the preliminary unaudited revenue information set forth in this release should not be relied upon as such. Readers should not expect Merit to make similar disclosures of preliminary unaudited revenue information in the future.<\/p>\n<p>Merit\u2019s audited consolidated financial statements at and for the year ended December 31, 2025 are not yet available. As a result, the financial information described in this release is preliminary and unaudited, and represents management\u2019s estimate as of the date hereof, and is subject to completion of Merit\u2019s financial closing procedures for the quarter and fiscal year ended December 31, 2025. These preliminary unaudited revenue results may materially differ from the actual results that will be reflected in Merit\u2019s audited consolidated financial statements when completed and publicly disclosed. Merit\u2019s independent registered public accounting firm has not conducted an audit or review of, and does not express an opinion or any other form of assurance with respect to, Merit\u2019s preliminary unaudited revenue results. Accordingly, the preliminary unaudited revenue information described in this release should not be relied on as necessarily predictive of Merit\u2019s actual results.<\/p>\n<p>The preliminary unaudited financial information presented in this release does not present all necessary information for a complete understanding of Merit\u2019s financial condition as of December 31, 2025, or Merit\u2019s results of operations for the year ended December 31, 2025. This preliminary unaudited financial data should not be viewed as a substitute for full financial statements for the year ended December 31, 2025 prepared in accordance with GAAP.<\/p>\n<p>TRADEMARKS<\/p>\n<p>Unless noted otherwise, trademarks and registered trademarks used in this release are the property of Merit Medical Systems, Inc.,\u202fits subsidiaries, or its licensors.<\/p>\n<p>\n        <u>CONTACTS<\/u>\n      <\/p>\n<p>PR\/Media Inquiries<br \/>Sarah Comstock<br \/>Merit Medical<br \/>+1-801-432-2864 |\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=IP25KM5BEcT-YvsFcZd7uKORVwOFoHnBYj4LWiwv9Dw4WclVMDSJW74OKIpYuV5MuwbMYE4wBw-JqCXZteCd_eNbvfwa6HppyCW03ZcH0nvEF3cg_fP4d_8w6TevHCbZhJajBB9UJewZw1Llm6rVPzBkoa2HiUWccnar5AjbgIBANiRmUzdugb8FpH-YBXCuVXkrtdQRKcRCNbxerYbxpkYK9z9fwJ6LCqh18paPS0FXnsOJ6bQaQxemYEBRNFde7QpLc3p6A1B9ttGXqWct95jqmt9Hm698Sw86Api6mPS4EqFkX8l3rFH1uj-tT7yWKJw2XIeaq84UBg5V77M1t0iZuHZ5YWKUvhJsKRbRDb-3YkLGAQD0WO5sO_T4uo3KSygNEcUFD1fbAq_G5CQOSozZdXclgMhdoHPb2IBzTPnWyMD4aGXYjSGDXtLO_gjgKqyElHw0OVENF7equZIKISR1ZmosNyjxjs5aL_BfO3kYFGROX_MnQ9SkYjGwqOfC9gxFrjYUGSPidx-kGxLGWtoB9E0b9ja7kewQGnEn_sTWSiSLVvqlYvVRWtS6W1RB\" rel=\"nofollow\" target=\"_blank\">sarah.comstock@merit.com<\/a><\/p>\n<p>Investor Inquiries<br \/>Mike Piccinino, CFA, IRC<br \/>ICR\u00a0Healthcare<br \/>+1-443-213-0509 |\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=BbcnjB23xW3Pewxa-YrYC2GBqp4fmTc8L_r9Aulj5_U6YT41qsnMZIggk7AdSFFC3JeUmDkoH3Vy4Y4zfYudud0zOSEgREkwHIE5296ws9B0E0-jp6tw8KnYYhYwIa3ajnmVpib93XgfhxNfSSvWdg==\" rel=\"nofollow\" target=\"_blank\">mike.piccinino@icrhealthcare.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYyMjQxMCM3MzUxNzIzIzIwMDg1MzY=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/YTcxZDEyNjItNGE0OS00MWJlLTgxNTUtYmNkNmE3NzE2Zjk0LTEwMjAxMDktMjAyNi0wMS0wOC1lbg==\/tiny\/Merit-Medical-Systems-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SOUTH JORDAN, Utah, Jan. 08, 2026 (GLOBE NEWSWIRE) &#8212; Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader in healthcare technology, today announced that its Board of Directors unanimously appointed F. Ann Millner, Ed.D., formerly Merit\u2019s Lead Independent Director, as Chair of the Board effective January 5, 2026. Dr. Millner has served as a director of Merit since 2015 and as the Lead Independent Director since July 2021. She previously served as the Chair of Merit\u2019s Governance and Sustainability Committee. Dr. Millner currently serves as a member of the Utah State Senate, to which she was elected in 2015. She served as the President of Weber State University from 2002 through 2012 and as the Regents Professor and Professor of &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/merit-medical-appoints-f-ann-millner-as-chair-of-the-board-and-announces-projected-preliminary-unaudited-revenue-results-for-the-fourth-quarter-of-2025\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Merit Medical Appoints F. Ann Millner as Chair of the Board and Announces Projected Preliminary Unaudited Revenue Results for the Fourth Quarter of 2025&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-925600","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Merit Medical Appoints F. Ann Millner as Chair of the Board and Announces Projected Preliminary Unaudited Revenue Results for the Fourth Quarter of 2025 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/merit-medical-appoints-f-ann-millner-as-chair-of-the-board-and-announces-projected-preliminary-unaudited-revenue-results-for-the-fourth-quarter-of-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Merit Medical Appoints F. Ann Millner as Chair of the Board and Announces Projected Preliminary Unaudited Revenue Results for the Fourth Quarter of 2025 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SOUTH JORDAN, Utah, Jan. 08, 2026 (GLOBE NEWSWIRE) &#8212; Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader in healthcare technology, today announced that its Board of Directors unanimously appointed F. Ann Millner, Ed.D., formerly Merit\u2019s Lead Independent Director, as Chair of the Board effective January 5, 2026. Dr. Millner has served as a director of Merit since 2015 and as the Lead Independent Director since July 2021. She previously served as the Chair of Merit\u2019s Governance and Sustainability Committee. Dr. Millner currently serves as a member of the Utah State Senate, to which she was elected in 2015. She served as the President of Weber State University from 2002 through 2012 and as the Regents Professor and Professor of &hellip; Continue reading &quot;Merit Medical Appoints F. Ann Millner as Chair of the Board and Announces Projected Preliminary Unaudited Revenue Results for the Fourth Quarter of 2025&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/merit-medical-appoints-f-ann-millner-as-chair-of-the-board-and-announces-projected-preliminary-unaudited-revenue-results-for-the-fourth-quarter-of-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-08T22:17:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYyMjQxMCM3MzUxNzIzIzIwMDg1MzY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"12 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/merit-medical-appoints-f-ann-millner-as-chair-of-the-board-and-announces-projected-preliminary-unaudited-revenue-results-for-the-fourth-quarter-of-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/merit-medical-appoints-f-ann-millner-as-chair-of-the-board-and-announces-projected-preliminary-unaudited-revenue-results-for-the-fourth-quarter-of-2025\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Merit Medical Appoints F. Ann Millner as Chair of the Board and Announces Projected Preliminary Unaudited Revenue Results for the Fourth Quarter of 2025\",\"datePublished\":\"2026-01-08T22:17:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/merit-medical-appoints-f-ann-millner-as-chair-of-the-board-and-announces-projected-preliminary-unaudited-revenue-results-for-the-fourth-quarter-of-2025\\\/\"},\"wordCount\":2447,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/merit-medical-appoints-f-ann-millner-as-chair-of-the-board-and-announces-projected-preliminary-unaudited-revenue-results-for-the-fourth-quarter-of-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTYyMjQxMCM3MzUxNzIzIzIwMDg1MzY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/merit-medical-appoints-f-ann-millner-as-chair-of-the-board-and-announces-projected-preliminary-unaudited-revenue-results-for-the-fourth-quarter-of-2025\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/merit-medical-appoints-f-ann-millner-as-chair-of-the-board-and-announces-projected-preliminary-unaudited-revenue-results-for-the-fourth-quarter-of-2025\\\/\",\"name\":\"Merit Medical Appoints F. Ann Millner as Chair of the Board and Announces Projected Preliminary Unaudited Revenue Results for the Fourth Quarter of 2025 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/merit-medical-appoints-f-ann-millner-as-chair-of-the-board-and-announces-projected-preliminary-unaudited-revenue-results-for-the-fourth-quarter-of-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/merit-medical-appoints-f-ann-millner-as-chair-of-the-board-and-announces-projected-preliminary-unaudited-revenue-results-for-the-fourth-quarter-of-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTYyMjQxMCM3MzUxNzIzIzIwMDg1MzY=\",\"datePublished\":\"2026-01-08T22:17:16+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/merit-medical-appoints-f-ann-millner-as-chair-of-the-board-and-announces-projected-preliminary-unaudited-revenue-results-for-the-fourth-quarter-of-2025\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/merit-medical-appoints-f-ann-millner-as-chair-of-the-board-and-announces-projected-preliminary-unaudited-revenue-results-for-the-fourth-quarter-of-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/merit-medical-appoints-f-ann-millner-as-chair-of-the-board-and-announces-projected-preliminary-unaudited-revenue-results-for-the-fourth-quarter-of-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTYyMjQxMCM3MzUxNzIzIzIwMDg1MzY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTYyMjQxMCM3MzUxNzIzIzIwMDg1MzY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/merit-medical-appoints-f-ann-millner-as-chair-of-the-board-and-announces-projected-preliminary-unaudited-revenue-results-for-the-fourth-quarter-of-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Merit Medical Appoints F. Ann Millner as Chair of the Board and Announces Projected Preliminary Unaudited Revenue Results for the Fourth Quarter of 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Merit Medical Appoints F. Ann Millner as Chair of the Board and Announces Projected Preliminary Unaudited Revenue Results for the Fourth Quarter of 2025 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/merit-medical-appoints-f-ann-millner-as-chair-of-the-board-and-announces-projected-preliminary-unaudited-revenue-results-for-the-fourth-quarter-of-2025\/","og_locale":"en_US","og_type":"article","og_title":"Merit Medical Appoints F. Ann Millner as Chair of the Board and Announces Projected Preliminary Unaudited Revenue Results for the Fourth Quarter of 2025 - Market Newsdesk","og_description":"SOUTH JORDAN, Utah, Jan. 08, 2026 (GLOBE NEWSWIRE) &#8212; Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader in healthcare technology, today announced that its Board of Directors unanimously appointed F. Ann Millner, Ed.D., formerly Merit\u2019s Lead Independent Director, as Chair of the Board effective January 5, 2026. Dr. Millner has served as a director of Merit since 2015 and as the Lead Independent Director since July 2021. She previously served as the Chair of Merit\u2019s Governance and Sustainability Committee. Dr. Millner currently serves as a member of the Utah State Senate, to which she was elected in 2015. She served as the President of Weber State University from 2002 through 2012 and as the Regents Professor and Professor of &hellip; Continue reading \"Merit Medical Appoints F. Ann Millner as Chair of the Board and Announces Projected Preliminary Unaudited Revenue Results for the Fourth Quarter of 2025\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/merit-medical-appoints-f-ann-millner-as-chair-of-the-board-and-announces-projected-preliminary-unaudited-revenue-results-for-the-fourth-quarter-of-2025\/","og_site_name":"Market Newsdesk","article_published_time":"2026-01-08T22:17:16+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYyMjQxMCM3MzUxNzIzIzIwMDg1MzY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"12 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/merit-medical-appoints-f-ann-millner-as-chair-of-the-board-and-announces-projected-preliminary-unaudited-revenue-results-for-the-fourth-quarter-of-2025\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/merit-medical-appoints-f-ann-millner-as-chair-of-the-board-and-announces-projected-preliminary-unaudited-revenue-results-for-the-fourth-quarter-of-2025\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Merit Medical Appoints F. Ann Millner as Chair of the Board and Announces Projected Preliminary Unaudited Revenue Results for the Fourth Quarter of 2025","datePublished":"2026-01-08T22:17:16+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/merit-medical-appoints-f-ann-millner-as-chair-of-the-board-and-announces-projected-preliminary-unaudited-revenue-results-for-the-fourth-quarter-of-2025\/"},"wordCount":2447,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/merit-medical-appoints-f-ann-millner-as-chair-of-the-board-and-announces-projected-preliminary-unaudited-revenue-results-for-the-fourth-quarter-of-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYyMjQxMCM3MzUxNzIzIzIwMDg1MzY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/merit-medical-appoints-f-ann-millner-as-chair-of-the-board-and-announces-projected-preliminary-unaudited-revenue-results-for-the-fourth-quarter-of-2025\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/merit-medical-appoints-f-ann-millner-as-chair-of-the-board-and-announces-projected-preliminary-unaudited-revenue-results-for-the-fourth-quarter-of-2025\/","name":"Merit Medical Appoints F. Ann Millner as Chair of the Board and Announces Projected Preliminary Unaudited Revenue Results for the Fourth Quarter of 2025 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/merit-medical-appoints-f-ann-millner-as-chair-of-the-board-and-announces-projected-preliminary-unaudited-revenue-results-for-the-fourth-quarter-of-2025\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/merit-medical-appoints-f-ann-millner-as-chair-of-the-board-and-announces-projected-preliminary-unaudited-revenue-results-for-the-fourth-quarter-of-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYyMjQxMCM3MzUxNzIzIzIwMDg1MzY=","datePublished":"2026-01-08T22:17:16+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/merit-medical-appoints-f-ann-millner-as-chair-of-the-board-and-announces-projected-preliminary-unaudited-revenue-results-for-the-fourth-quarter-of-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/merit-medical-appoints-f-ann-millner-as-chair-of-the-board-and-announces-projected-preliminary-unaudited-revenue-results-for-the-fourth-quarter-of-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/merit-medical-appoints-f-ann-millner-as-chair-of-the-board-and-announces-projected-preliminary-unaudited-revenue-results-for-the-fourth-quarter-of-2025\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYyMjQxMCM3MzUxNzIzIzIwMDg1MzY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYyMjQxMCM3MzUxNzIzIzIwMDg1MzY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/merit-medical-appoints-f-ann-millner-as-chair-of-the-board-and-announces-projected-preliminary-unaudited-revenue-results-for-the-fourth-quarter-of-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Merit Medical Appoints F. Ann Millner as Chair of the Board and Announces Projected Preliminary Unaudited Revenue Results for the Fourth Quarter of 2025"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/925600","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=925600"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/925600\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=925600"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=925600"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=925600"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}